Related Experiment Video
Updated: Feb 11, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Potential of siRNA-albumin complex against cancer
Na Liu1, Yan-Hua Qi1, Chuan-Tao Cheng2
1Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Abstract:
RNA interference is a highly specific as well as efficient technology for gene therapy application in molecular oncology. The present study was planned to develop an efficient and stable tumor selective delivery mechanism for siRNA gene therapy for the purpose of both diagnosis as well as therapy. We have used 20 Male wistar rats for the formation of colon cancer model and utilized albumin as carrier molecule for the delivery of siRNA against vascular endothelial growth factor receptor 2 (VEGF R2). The study results confirmed efficient delivery of siRNA at tumor site as confirmed by tagging of siRNA-albumin complex with 99mTC. Moreover, the expression of VEGF also showed decline after efficient delivery of siRNA at tumor site. The study concluded that albumin is an efficient molecule for the efficient delivery of siRNA at tumor sites.
Insights
Albumin effectively delivers small interfering RNA (siRNA) to colon cancer tumors in rats. This targeted delivery of siRNA for vascular endothelial growth factor receptor 2 (VEGF R2) shows promise for cancer therapy.
Area of Science:
- Molecular Oncology
- Gene Therapy
- Nanomedicine
Background:
- RNA interference (RNAi) is a potent gene therapy tool.
- Developing tumor-selective delivery systems for siRNA is crucial for cancer treatment.
- Targeting VEGF R2 is a key strategy in inhibiting tumor growth.
Purpose of the Study:
- To develop a stable, tumor-selective delivery system for siRNA using albumin.
- To evaluate albumin as a carrier for siRNA in a colon cancer model.
- To assess the diagnostic and therapeutic potential of this siRNA delivery system.
Main Methods:
- A colon cancer model was established in 20 male Wistar rats.
- Albumin was used as a carrier molecule for siRNA targeting VEGF R2.
- siRNA-albumin complexes were labeled with 99mTc for tracking delivery.
Main Results:
- Efficient delivery of siRNA to the tumor site was confirmed via 99mTc labeling.
- A significant decline in VEGF expression was observed post-siRNA delivery.
- Albumin demonstrated effective tumor-selective delivery of siRNA.
Conclusions:
- Albumin is a suitable and efficient carrier for targeted siRNA delivery in cancer therapy.
- This approach holds potential for both diagnostic and therapeutic applications in oncology.
- Targeted delivery of VEGF R2 siRNA using albumin can inhibit tumor progression.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Small interfering RNAs (siRNA)
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Standard Electrode Potentials

